Trailing-twelve-month (TTM) revenue is $7.46 Billion with a year-over-year growth of +17.93%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,986,968,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $1,888,046,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $1,684,701,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q2 FY2026Period ended 2026-06-30 | $1,897,965,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $7,457,680,000 |
Current P/S: $13,247,460,640 market capitalization ÷ $7,457,680,000 TTM revenue = 1.78x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.90B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T23:20:20.006Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Advanced Products | $3.2B | $4.4B | $5.4B | $5.0B | $5.2B | $5.6B |
| Mainstream Products | $1.8B | $1.7B | $1.7B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $673M | $1000M | $1.0B | $705M | $716M | N/A |
| Asia Pacific (Excluding Japan) | N/A | N/A | N/A |
$7.46B
$7.46 Billion
+17.93%
vs. $6.32B a year ago (TTM)
+6.44%
5 Year compound annual growth rate
1 Year
+17.93%
3 Year
+2.53%
5 Year
+6.44%
10 Year
+8.86%
15 Year
+6.51%
20 Year
+5.56%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $6.71B | +$390.29M | +6.18% |
| 2024 | $6.32B | ($185.37M) | (2.85%) |
| 2023 | $6.50B | ($588.52M) | (8.30%) |
| 2022 | $7.09B | +$953.26M | +15.53% |
| 2021 | $6.14B | +$1.09B | +21.54% |
| 2020 |
TTM Growth
+17.93%
3-Year CAGR
+2.53%
5-Year CAGR
+6.44%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T23:20:20.006Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.1B |
| $1.2B |
| N/A |
| N/A |
| $733M |
| EMEA | $848M | $1.1B | $1.1B | $1.0B | $818M | $853M |
|---|
| JAPAN | $1.2B | $1.3B | $1.1B | $936M | $801M | $725M |
|---|
| Non-US | N/A | N/A | N/A | N/A | N/A | $2.3B |
|---|
| UNITED STATES | $2.4B | $2.8B | $3.9B | $3.8B | $4.0B | $4.4B |
|---|
| $5.05B |
| +$997.94M |
| +24.62% |
| 2019 | $4.05B | ($263.82M) | (6.11%) |
| 2018 | $4.32B | +$129.97M | +3.10% |
| 2017 | $4.19B | +$292.86M | +7.52% |
| 2016 | $3.89B | +$1.01B | +34.98% |
